Stemsation International, Inc (STSN) Fair Value & Analysis
Healthcare · US · Market cap $1.6M
Stemsation International, Inc
STSN · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.0800 to $0.0038 (−95.2%) since Jun 24, 2026. Share price +133.3% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0012 – $0.0077 · fair‑value band $0.0038 – $0.0042 · the $0.0036 price screens below the $0.0038 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Stemsation International, Inc (STSN) currently trades at $0.0036, while our model-based Fair Value estimate is $0.0038 — implying the stock looks roughly 6.4% undervalued today. We read business quality at 39/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Net debt stands at $1.5M. Fundamentals as of Jun 26, 2026
About the company
Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.
Revenue & earnings trend
FY2010 – FY2025 · reported fiscal years
Stemsation International, Inc reported revenue of $217K in FY2020 versus $3.4K in FY2010, a compound +51.6%/yr. Reported net income was −$464K in FY2025.
Is STSN fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Zoetis Inc Z1TS34 | R$25.93 | R$19.70 | -24% |
| Hansoh Pharmaceutical Group 3692 | HK$29.30 | HK$23.90 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,639 | ₹1,281 | -81% |
| Swedish Orphan Biovitrum AB SOBI | kr 446.60 | kr 234.19 | -48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Stemsation International, Inc (STSN) undervalued?
What is the fair value of STSN?
What is the quality score of STSN?
What is the net profit margin of STSN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.